ArticleScientific reports2021

A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3).

Dylan R Rivas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.